MedPath

Far Infrared Radiation for Sickle Cell Pain Management

Phase 1
Conditions
Anemia, Sickle Cell
Interventions
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Registration Number
NCT00599482
Lead Sponsor
GAAD Medical Research Institute Inc.
Brief Summary

Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.

Detailed Description

Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue.

It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • People with sickle cell disease
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Far Infrared Radiation (5μm to 20μm wavelength)Far Infrared Radiation
Primary Outcome Measures
NameTimeMethod
Pain Management40 minutes
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Centre for Incurable Diseases

🇨🇦

Mississauga, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath